NAT10 and neoplasm: Moreover, the NAT10–ac4C–FOXP1 axis has been identified to augment lactic acid production and bolster glycolytic activity in CCa cells, thereby intensifying the immunosuppressive characteristics of tumor-infiltrating regulatory T cells.